Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. - Uherek,C.; Tonn,T.; Uherek,B.; Becker,S.; Schnierle,B.; Klingemann,HG.; Wels,W. (Blood, 2002)